Idiopathic acquired pure red cell aplasia (PRCA) is a rare, autoimmune-related disease. This study aimed to describe the previously unidentified DNA alterations associated with PRCA. Here, next generation sequencing using a panel containing 295 critical genes was applied to detect potentially pathogenic mutations in four patients with PRCA. A total of 529 mutations were identified and further classified into three categories, namely, uncertain (n = 25), likely benign (n = 20) and benign (n = 484) mutations, based on the American College of Medical Genetics and Genomics (ACMG) 2015 guidelines and ClinVar database. The spatial proximity between two loci of the uncertain or benign mutations was evaluated using Hi-C datasets of KBM7 and K562 cell lines, respectively. Significant spatial proximity was observed in uncertain mutation pairs compared with benign mutation pairs. In addition, 17 variants were eventually identified after excluding those with mutant frequencies >0.001, including 7 newly identified variants. FANCF and LRP1B mutations existed twice in patients. FANCF and LRP1B mutations were likely to affect protein stability based on prediction analysis. Taken together, our data may provide valuable information about PRCA. FANCF and LRP1B mutations may be associated with acquired PRCA.
Introduction
Pure red cell aplasia (PRCA) is a rare disease characterized by a severe normocytic anemia, reticulocytopenia and absence of erythroblasts from the bone marrow [1] . Acquired PRCA, which is distinguished from congenital forms of PRCA, is associated with autoimmune, infections, solid tumors, lymphoproliferative disorders, autoimmune vascular diseases, or specific medications [2] .
PRCA is managed using immunosuppressive therapy with corticosteroids or cyclosporine A after failure to respond to the treatment of underlying diseases. However, relapse commonly occurs in most cases, partly due to the limited understanding of the pathogenesis of acquired PRCA [3] .
Evidence has demonstrated that gene mutations are involved in both congenital and acquired blood diseases. specifically, 60%-70% of Diamond-Blackfan anemia cases are caused by mutations in ribosomal genes such as RPS19 and RPL5 [4] . Genetic alterations of perforin may represent a risk factor for acquired aplastic anemia [5] . In Asian cohorts with large granular lymphocyte leukemia, STAT3 gene mutations are associated with acquired PRCA [6] . However, insufficient information is available on the characteristics of mutations in acquired PRCA patients. It is therefore necessary to explore whether genetic alterations play a critical role in the development of acquired PRCA.
Chromatin functions in the formation of a high-order structure that includes genomic DNA and epigenetic and genetic regulators. In recent years, studies have indicated that the 3D conformation of chromatin functions in numerous nuclear processes such as gene expression regulation, DNA replication, and epigenetic organization [7] [8] [9] [10] [11] [12] [13] [14] . Researchers have developed a genome-wide chromatin conformation capture technology (Hi-C) and applied it to assess the chromatin spatial organization. This technique can help researchers understand the genome 3D structures and their relationships to disease initiation and progression [12, [15] [16] [17] [18] .
The current study attempted to identify the genetic alterations in patients with acquired PRCA using next generation sequencing (NGS) technology. Prediction analysis of variant-related protein function changes were performed to further reveal the possible pathways affected by variants.
Materials and Methods

Sample collection and DNA extraction
The diagnosis of PRCA requires both peripheral blood and bone marrow examination. Generally, reticulocyte percentage in PRCA patient's peripheral blood is <1% with lower hemoglobin content, while the white blood count and platelet count are normal. At the same time, in bone marrow examination, erythroblasts are absent or nearly absent (<1% on the marrow differential count) with normal myeloid granulocytes and megakaryocytes [2] . All patients included met these criteria. The patients with acquired PRCA in our study are idiopathic. PRCA patients caused by other diseases like infections, especially B19 parvovirus; solid tumors, particularly thymoma; drugs; hematologic malignancies and other known conditions were excluded. The definition of response to immune-suppressive therapy was described previously [1, 19] . Complete remission was defined as the achievement of normal hemoglobin level without transfusion and partial remission was interpreted as the presence of anemia but without transfusion dependence.
For genetic analyses, peripheral blood mononuclear cells were isolated from whole bloods of patients with PRCA. This study was approved by the Ethics Committee of Shanghai Jiao Tong University School of Medicine. Blood samples from patients with PRCA were collected after written informed consent. Genomic DNA extraction was performed using the QIAamp DNA kit (Qiagen, Hilden, Germany). The DNA quality and quantity were assessed with a NanoDrop TM 8000 spectrophotometer and a Qubit ® 3.0 fluorom- 
Classification of DNA alterations
Based on 2015 ACMG [20] , there are 28 criteria for classifying variants: 16 criteria for pathogenic or likely pathogenic criterion and 12 criteria for benign or likely benign criterion. The variant is assigned to uncertain significance if a variant does not meet criteria mentioned above, or evidence for pathogenic and benign is contradictory. Scoring rules based on the combination of the criteria allow a given variant to fall into one of five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign.
Hi-C datasets
The Hi-C technology provides genome-wise chromatin 3D conformation knowledge. With Hi-C data, one can evaluate the spatial proximity between any given chromatin loci. In this study, we first generated all pairs of mutations, of the two categories, uncertain and benign, respectively. Then we obtained the contact frequencies (reversely correlated to spatial distances) of all the mutation pairs, using two Hi-C datasets [7, 12] . Although in optimal cases, the samples' Hi-C data should be adopted, we used two different Hi-C data to obtain a consensus observation, due to resource limitation and considering the chromatin 3D conformation was reserved to a large extent especially for similar cell lines,.
Prediction of point mutation
PolyPhen-2 was used to predict the functional importance of an amino acid substitution of a protein. The details of PolyPhen-2 underlying principles and algorithm have been described previously [21] . Briefly, it calculates the naive Bayes posterior probability and appraises a mutation as benign, possibly damaging or probably damaging [21] . We performed STRUM to predict the impact on protein stability upon single-point mutation. STRUM makes predictions in terms of thermodynamics. The free energy gap difference ΔΔG is a measure of stability change. If a ΔΔG is above zero, it means that the substitution induces stabilization; otherwise, it causes destabilization [22] . FANCF crystal structure was downloaded from PDB [23] , and LRP1B 3D model was predicted by I-TASSER [24] .
PyMOL [25] was used to analyze the protein structure before and after the mutation.
Gene enrichment analysis
Protein-protein interactions were obtained from STRING [26] . Then GSEA [27] was used to investigate the common pathways or biological processes involved by proteins interacting with FANCF or LRP1B.
Results
Variants in the uncertain category were more spatially proximity than mutations in the benign group
To explore the mutations in patients with PRCA, peripheral blood lymphocyte DNA of four cases were subject to a 295-gene-panel sequencing. The details of patient information were shown in Supplementary Table S1 . The work flow of sequencing was shown in Fig. 1 'Uncertain' in this study is the same meaning as 'uncertain significance' in 2015 ACMG. There was no mutation meeting pathogenic or likely pathogenic category in our results. To explore the spatial proximate in different categories, we used two Hi-C datasets and found that the mutations of the uncertain category were spatially more proximate to each other in general, compared with the mutations of the benign group. The results also suggested that the linear distances between the uncertain mutations were generally closer than the linear distances of the benign mutations, but the linear distance was not the only contributor to the spatial proximity of the mutations of both categories (Fig. 2) . Work flow of identification of DNA alterations Low quality reads were removed. BWA was used to map sequencing data, then GATK 3.2 and VarScan were performed for annotation. ExAC, 1000 Genomes, dbSNP, ESP6500SI-V2 databases were employed for identifying SNP. The remaining variants were annotated through ANNOVAR and SnpEff v3.6. software Figure 2 . Spatial proximity comparison of mutation pairs of different categories The chromatin spatial proximity of mutation pairs of the two categories, uncertain and benign were compared under two Hi-C datasets, KBM7 (A) and K562 (B), respectively. Their contact frequency (reversely correlated to spatial proximity) distributions were shown in the upper panels. The linear distances of mutation pairs of the two categories were also compared, which was shown in the lower panels.
Identification of 17 mutations by sequencing in four PRCA patients
Considering that acquired PRCA is a rare disease, we omitted the variants of which frequency in population was more than 0.001. The result showed that 17 mutations were identified after filtering and 17 variants were located in 15 genes (FANCF, PIK3C3, DNMT3A, LRP1B, RAD51B, NF1, CARD11, NOTCH1, AR, RB1, PALB2, EPHA5, EP300, FAT3, and NSD1). The filter process was shown in Table 1 . The details of 17 mutations were shown in Table 2 .
FANCF and LRP1B mutations may affect protein stability
Venn diagram showed that among 17 mutations, mutations in FANCF and LRP1B appeared twice in patients (Fig. 3A) . We further studied these two genes. Variant positions in FANCF and LRP1B were all conserved (Fig. 3B, i and ii) . Then PolyPhen-2 [21] was used to predict the functional effects of the two different mutations found in FANCF. The higher PolyPhen-2 scores indicated that the higher probability of substitution was damaging. The R61L was benign with a score of 0.404 while the I346S was probably damaging with a score of 0.997 (Fig. 3B, i) . Further analysis was then performed on the I346S variant. STRUM [22] was used to predict the protein stability change upon I346S and the ΔΔG value was the indicator of STRUM results. A score below zero after calculation normally means less stable, and the value I346S scored −0.2 ( Table 3) . Hydrophobic Ile substituted with hydrophilic Ser may yield alteration of the protein structure, even phosphorylation modification on Ser. Next, PyMOL [25] was used to analyze the 3D structure. The Ser may alter the hydrophobic interaction (Fig. 3C, i) and the potential modification to this residue may change the protein conformation. Next, LRP1B was examined. Both mutation D3815E and mutation A3882V were possibly damaging with a score of 0.935 and 0.952 as revealed by PolyPhen-2 respectively (Fig. 3B, ii) . STRUM was used again to predict the protein stability change upon D3815E and A3882V with the ΔΔG of 4.23 and 5.81 respectively ( Table 3) . It seemed that the LRP1B protein was more stable upon these mutations in terms of thermodynamics. Then, PyMOL was applied to explore LRP1B protein structure before and after mutation (Fig. 3C , ii and iii). Although Asp and Glu are acidic amino acids, Glu has one more methyl group than Asp. The similar phenomenon was observed with A3882V. Both Ala and Val are neutral amino acids, but Val has two more methyl groups than Ala. The larger amino acid side chain group may change the molecular-molecular interaction.
Common biological processes FANCF and LRP1B may affect
To explore the pathways or biological processes FANCF and LRP1B may affect, we did the following analysis. Firstly, STRING [26] was performed to search proteins that interact with them. The left part were proteins associated with FANCF and the right part were proteins interacting with LRP1B (Fig. 4) . Then GSEA [27] was used to investigate the common biological processes that these proteins may participate in. The genes in dotted green box may be involved in cellular response to stress. The genes encircled with dashed red lines may participate in the cellular response to DNA damage stimulus. These pathways may contribute to the PRCA.
Discussion
Here, NGS was performed to help us understand this disease. First, DNA was extracted from blood samples from four PRCA patients, and NGS was used with a 295-gene-panel to explore mutations. Then we explored spatially proximity in chromatin conformation for different clinical significance degrees. Next, PolyPhen-2 [21] was used to predict the potential effect of the point mutation on this protein. We then used the PyMOL [25] and STRUM [22] to explore the protein configuration before and after the point mutation. Finally, STRING [26] was applied to obtain proteins interacting with FANCF and LRP1B. The genes obtained from STRING were combined as a gene set and investigated using the GSEA overlap tool [27] to evaluate the common pathways, processes or underlying biological themes in which genes in the provided gene set were involved.
The upper panels of Fig. 2 indicated that the uncertain mutation pairs were significantly more proximate to each other compared with the mutation pairs of the benign category, in the KBM7 and K562 Hi-C dataset. We further explored the linear distances of the uncertain mutation pairs and the benign mutation pairs to investigate to what extent the spatial proximity was due to linear proximity. Based on the P-values, the linear proximity played a minor role in spatial proximity. These findings suggest that the uncertain mutations which are more likely to cause diseases compared with benign mutations which are likely to occur in a chromatin co-mutation pattern (spatial The two point mutation regions in FANCF (i) and LRP1B (ii) are highly conserved between four species. PolyPhen-2 was applied to predict the possible impact of an amino acid substitution on the structure and function of a human protein. The PolyPhen-2 scores ranked in red area meaning the higher probability of damaging substitution (i and ii). (C) Structural analysis of FANCF and LRP1B in wild-type and mutants using PyMOL. (i) FANCF protein conformation before and after the amino acid mutation at position 346. LRP1B protein conformation before and after the amino acid mutation at position 3815 (ii) and 3882 (iii), respectively. co-mutation hotspots). We hypothesize that this phenomenon may be due to mutation-causing factors, such as certain chemicals or dysfunctional repair protein in specific chromatin 3D loci. Our NGS data revealed that LRP1B and FANCF variants appeared twice in four PRCA patients, so we focused on these two genes (Fig. 3) . The first FANCF variant (G128T) in patient 4 affected exon 1, and resulted in the substitution of Arg residue with Leu. Although the prediction result we obtained from PolyPhen-2 was benign, the change from the basic amino acid Arg to a neutral amino acid Leu may have affected the hydrophobicity of the protein. Thus, this mutation has the potential to influence the protein structure which determines the protein function. The second FANCF mutation (T1037G) was found to locate in exon 1 in patient 1, resulting in the substitution of the Ile amino acid residue with Ser at position 346. Based on a previous study [28] , the protein sequence spanning Leu-329 to Leu-352 is highly conserved, which is crucial for FANCF function as a connector assembling the FA core complex correctly. Both predictions from PolyPhen-2 and STRUM indicated that the FANCF variant (T1037G) might destroy the protein function. The same analysis was performed for LRP1B variants. Although STRUM predicted that the effects of two mutations C11645T in patient 1 and T11445G in patient 2 on LRP1B protein stability were positive, the prediction results from PolyPhen-2 indicated that these two variants were both possibly damaging. PolyPhen-2 uses predictive features, which is selected by an iterative greedy algorithm, not only incorporating sequence conservation and property of substitution but also considering the position of the amino acid residue. Next, we searched the proteins associated with FANCF and LRP1B using STRING. To explore the possible common pathways shared by FANCF-and LRP1B-related proteins, we used the GSEA overlap function to find two main involved pathways or processes: cellular response to stress and cellular response to DNA damage stimulus. The possible malfunctions of FANCF and LRP1B may disrupt these pathways, which contributes to disease processes.
It is generally acknowledged that Ser can be phosphorylated, which plays a key role in modifying protein function through altering the structural conformation. Abnormal protein phosphorylation could lead to human diseases such as Parkinson's disease and Alzheimer's disease [29, 30] . Modulating protein phosphorylation may also cure diseases. Hydroxyurea is useful in the treatment of sickle cell disease partly through inhibiting Lu/BCAM phosphorylation [31] . Protein phosphorylation may occur at position 346 when Ile was replaced by Ser, which may result in improper protein folding and signaling abnormalities.
FANCF is essential for genomic DNA repair and mitophagy function [28, 32, 33] . Mutations of FANCF have been identified in Fanconi anemia individuals using NGS [34] . Acquired PRCA is mainly considered as an immunologically mediated disorder, when patients exhibit no response to the treatment of underlying diseases [1] . A recent study unveiled the role of Fanconi anemia proteins including FNACF in mitophagy and immunity. These proteins function in preventing inflammasome activation and in selective autophagy [33] .
Protein structures of LRP1B variants in patients 1 and 2 were slightly more stable, given that both of ΔΔG scores were >0 predicted by STRUM. These variants potentially play a protective role. However, hypermorphs could also contribute to diseases. For example, SOS1 mutants are associated with Noonan syndrome and enhance RAS and ERK activation [35] .
In addition to physiologically reduced expressions of HLA class I genes in erythropoietic progenitors, unknown ligands on these cells recognized by large granular lymphocytes could lead to lymphocytemediated inhibition of erythropoiesis [36] . The unknown ligands may be the products of mutations identified in this study. Further experiments should be performed to evaluate the single-point mutation.
NGS is a useful tool to identify mutations. As the mutation allele fractions (MAFs) we obtained are around 50% (30%-60%), the variants were more likely to be germline origin. However, given that PRCA is a hematologic disorder, the possibility of somatic origin can not be excluded. Seventeen mutations were identified as potential candidates associated with PRCA. Analysis of literatures revealed that 7 of these mutations were novel: FANCF (c.1037T > G), PIK3C3 (c.2189C > G), LRP1B (c.11645C > T), RAD51B (c.905A > G), NOTCH1 (c.811G > A), NSD1 (c.3917A > G), and PALB2 (c.3341A > G). DNMT3A (c.958C > T) has been reported in advanced prostate cancer and acute myeloid leukemia [37, 38] . NF1 (c.5084G > A) was found in colorectal cancer cell lines [39] . CARD11 (c.2899C > T) has been reported in esophageal squamous cell carcinoma [40] . EPHA5 (c.316G > A) was identified in colorectal cancers [41] . Given that the pathogenesis of acquired PRCA is heterogeneous, these variants may collectively contribute to PRCA predisposition.
In conclusion, uncertain mutation pairs showed significantly more spatial proximate to each other than the mutation pairs of the benign group. In addition, 17 mutations were identified after filtering using NGS and they might be associated with acquired PRCA. These results provide valuable insight into possible causes of acquired PRCA.
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